Insights

Innovative Therapeutics Focus Pliant Therapeutics specializes in integrin-based therapeutics targeting unmet medical needs, presenting opportunities to collaborate with biotech companies and pharmaceutical firms seeking cutting-edge solutions in fibrosis and inflammatory diseases.

Active Industry Engagement Regular participation in prominent industry conferences like ATS and J.P. Morgan Healthcare indicates strong market presence and networking potential for strategic partnerships and alliances with key healthcare stakeholders.

Significant Funding Backbone With a robust funding base of 288 million dollars, Pliant is positioned for ongoing research and development investments, making it an attractive partner for investors and enterprise solutions supporting biopharmaceutical innovation.

Leadership Expansion Recent hires of senior executives including a CTO and SVP of Medical Affairs highlight opportunities to offer specialized medical and technical services, as well as executive-level consultancies tailored to their growth trajectory.

Market Position and Potential Operating in a competitive biotech landscape with a focused portfolio, Pliant's strategic expansion and pipeline development provide avenues for sales of raw materials, research tools, or partnership opportunities to accelerate their drug discovery efforts.

Pliant Therapeutics Tech Stack

Pliant Therapeutics uses 8 technology products and services including jQuery CDN, Workiva, Lightbox, and more. Explore Pliant Therapeutics's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Workiva
    Governance, Risk And Compliance
  • Lightbox
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • Flywheel
    Platform As A Service
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • GoDaddy
    Web Hosting

Media & News

Pliant Therapeutics's Email Address Formats

Pliant Therapeutics uses at least 1 format(s):
Pliant Therapeutics Email FormatsExamplePercentage
FLast@pliantrx.comJDoe@pliantrx.com
89%
LastFirst@pliantrx.comDoeJohn@pliantrx.com
6%
Last@pliantrx.comDoe@pliantrx.com
3%
FirstLast@pliantrx.comJohnDoe@pliantrx.com
2%

Frequently Asked Questions

Where is Pliant Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Pliant Therapeutics's main headquarters is located at 331 Oyster Point Blvd, South San Francisco, California 94080, US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Pliant Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Pliant Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Pliant Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Pliant Therapeutics is a publicly traded company; the company's stock symbol is PLRX.

What is Pliant Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Pliant Therapeutics's official website is pliantrx.com and has social profiles on LinkedInCrunchbase.

What is Pliant Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Pliant Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pliant Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, Pliant Therapeutics has approximately 135 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Technical Officer: D. I.Chief Regulatory Officer And Head Of Quality: S. M. G.Vice President Of Quality: E. G.. Explore Pliant Therapeutics's employee directory with LeadIQ.

What industry does Pliant Therapeutics belong to?

Minus sign iconPlus sign icon
Pliant Therapeutics operates in the Biotechnology Research industry.

What technology does Pliant Therapeutics use?

Minus sign iconPlus sign icon
Pliant Therapeutics's tech stack includes jQuery CDNWorkivaLightboxMicrosoftFlywheelBootstrapX-Content-Type-OptionsGoDaddy.

What is Pliant Therapeutics's email format?

Minus sign iconPlus sign icon
Pliant Therapeutics's email format typically follows the pattern of FLast@pliantrx.com. Find more Pliant Therapeutics email formats with LeadIQ.

How much funding has Pliant Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2025, Pliant Therapeutics has raised $288M in funding. The last funding round occurred on Jan 24, 2023 for $288M.

When was Pliant Therapeutics founded?

Minus sign iconPlus sign icon
Pliant Therapeutics was founded in 2015.
Pliant Therapeutics

Pliant Therapeutics

Biotechnology ResearchUnited States51-200 Employees

Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the discovery and development of integrin-based therapeutics. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients. 

We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates.

Pliant is an equal opportunity employer and does not discriminate against any individual or potential candidate based on race, color, religion, sex, national origin, sexual preference or any other legally protected category.

Pliant is located in South San Francisco, California, the birthplace of biotechnology. 

Learn more about how we are the leader in the discovery and development of integrin-based therapeutic at www.PliantRx.com.

Section iconCompany Overview

Headquarters
331 Oyster Point Blvd, South San Francisco, California 94080, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PLRX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $288M

    Pliant Therapeutics has raised a total of $288M of funding over 5 rounds. Their latest funding round was raised on Jan 24, 2023 in the amount of $288M.

  • $1M$10M

    Pliant Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $288M

    Pliant Therapeutics has raised a total of $288M of funding over 5 rounds. Their latest funding round was raised on Jan 24, 2023 in the amount of $288M.

  • $1M$10M

    Pliant Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.